| 2020 | Anti-Inflammatory Effect for Atherosclerosis Progression by Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor in a Normoglycemic Rabbit Model | 김충기 | Article |
| 2019 | Aortic Stenosis and Transcatheter Aortic Valve Implantation: Current Status and Future Directions in Korea | 김충기 | Review |
| 2022 | Benefit and risk of prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with chronic kidney disease: A nationwide cohort study | 김충기 | Article |
| 2022 | Clinical Implications of Poststent Optical Coherence Tomographic Findings: Severe Malapposition and Cardiac Events | 김충기 | Article |
| 2023 | Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention | 김충기 | Article |
| 2021 | Consensus Decision-Making for the Management of Antiplatelet Therapy before Non-Cardiac Surgery in Patients Who Underwent Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents: A Cohort Study | 김충기 | Article |
| 2022 | Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling | 김충기 | Article |
| 2024 | Handheld 6-Lead ECG for Early Detection of Acute Inferior Wall ST-T Segment Elevation Myocardial Infarction: HINT-MI Study Design and Rationale | 박준범; 강인숙; 김충기; 신상훈; 정소담 | Article |
| 2022 | Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention | 김충기 | Article |
| 2023 | Perioperative Antiplatelet Strategy in Patients Undergoing Noncardiac Surgery Within One Year After Percutaneous Coronary Intervention | 김충기; 신상훈 | Article |
| 2022 | Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study | 김충기 | Article |
| 2020 | Risk stratification by SYNTAX score systems in current percutaneous revascularization era | 김충기 | Article |
